Cost-utility analysis of germline BRCA1/2 testing in women with high-grade epithelial ovarian cancer in Spain.
Clin Transl Oncol
; 21(8): 1076-1084, 2019 Aug.
Article
in En
| MEDLINE
| ID: mdl-30617925
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Genetic Testing
/
Health Care Costs
/
Cost-Benefit Analysis
/
Germ-Line Mutation
/
BRCA1 Protein
/
BRCA2 Protein
/
Carcinoma, Ovarian Epithelial
Type of study:
Diagnostic_studies
/
Health_economic_evaluation
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Female
/
Humans
/
Middle aged
Country/Region as subject:
Europa
Language:
En
Journal:
Clin Transl Oncol
Year:
2019
Type:
Article
Affiliation country:
Spain